Skip to main content

Candriam S.C.A.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1537014 STRASSEN, N4

Position in REGN

as of Mar 31, 2026 · filed Apr 30, 2026
Position Value
$144,010,824
-$14,478,786 QoQ
Shares Held
186,388
-9.2% QoQ
Ownership
0.178%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Candriam S.C.A. holds $1,920,933,361 across 79 Biotechnology names. REGN ranks #1 (7.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
This page
186,388 $144,010,824

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $144,010,824 186,388
2025-12-31 $158,489,610 205,332
2025-09-30 $95,301,953 169,495
2025-06-30 $74,659,200 142,208
2025-03-31 $136,322,029 214,941
2024-12-31 $186,272,869 261,498
2024-09-30 $265,464,381 252,525
2024-06-30 $210,950,129 200,708
2024-03-31 $209,602,409 217,771
2023-12-31 $212,210,673 241,618
2023-09-30 $238,913,516 290,310
2023-06-30 $219,598,756 305,618
2023-03-31 $286,752,969 348,988
2022-12-31 $276,307,581 382,968
2022-09-30 $277,284,641 402,521
2022-06-30 $220,369,125 372,793
2022-03-31 $257,919,521 369,290
2021-12-31 $230,243,350 364,586
2021-09-30 $235,198,970 388,643
2021-06-30 $296,219,454 530,346
2021-03-31 $190,978,702 403,641
2020-12-31 $195,001,070 403,637
2020-09-30 $180,829,091 323,036
2020-06-30 $142,754,107 228,901
2020-03-31 $200,792,660 411,216